Literature DB >> 11570580

Mutation and overexpression of the beta-catenin gene may play an important role in primary hepatocellular carcinoma among Chinese people.

J Cui1, X Zhou, Y Liu, Z Tang.   

Abstract

AIM: To study the role of beta-catenin gene mutation and expression in hepatocellular carcinogenesis.
METHOD: Thirty-four hepatocellular carcinoma (HCC) specimens and adjacent para-cancerous tissues, and four normal liver tissues were analyzed. Subcellular distribution of beta-catenin was examined by immunohistochemistry staining. Mutation and semiquantitative expression of beta-catenin gene exon 3 mRNA were detected by RT-PCR-SSCP and in situ hybridization. RESULT: Immunohistochemistry showed that all normal liver tissues and para-cancerous tissues examined showed membranous-type staining for beta-catenin protein, frequently with weak expression in the cytoplasm, but no beta-catenin accumulation in nuclei was found; while in liver cancer, 21 cases (61.8%) of HCC examined showed accumulated type in cytoplasms or nuclei. On SSCP, 15 cases (44.1%) of HCC altogether displayed three kinds of characteristic mutational mobility shifts. No abnormal shifting bands were found in tissues from normal liver or para-cancerous area. The beta-catenin gene exon 3 mRNA expression index of 34 HCCs was higher than that of para-cancerous tissue and normal liver tissue. Using in situ hybridization, the signal corresponding to beta-catenin gene exon 3 mRNA was particularly strong in cytoplasm of HCC when compared with those of paracancerous tissues and normal liver tissues.
CONCLUSION: beta-catenin gene mutation and overexpression may have a critical role in malignant progression of hepatic carcinogenesis among Chinese people.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11570580     DOI: 10.1007/s004320100259

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  11 in total

1.  PROX1 promotes hepatocellular carcinoma proliferation and sorafenib resistance by enhancing β-catenin expression and nuclear translocation.

Authors:  Y Liu; X Ye; J-B Zhang; H Ouyang; Z Shen; Y Wu; W Wang; J Wu; S Tao; X Yang; K Qiao; J Zhang; J Liu; Q Fu; Y Xie
Journal:  Oncogene       Date:  2015-02-16       Impact factor: 9.867

Review 2.  Wnt signaling in liver cancer.

Authors:  Yutaka Takigawa; Anthony M C Brown
Journal:  Curr Drug Targets       Date:  2008-11       Impact factor: 3.465

3.  Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma.

Authors:  Bin Yang; Mingzhou Guo; James G Herman; Douglas P Clark
Journal:  Am J Pathol       Date:  2003-09       Impact factor: 4.307

4.  p53 Plays an important role in cell fate determination after exposure to microcystin-LR.

Authors:  Shota Takumi; Masaharu Komatsu; Tatsuhiko Furukawa; Ryuji Ikeda; Tomoyuki Sumizawa; Hitomi Akenaga; Yuta Maeda; Kohji Aoyama; Koji Arizono; Seiichi Ando; Toru Takeuchi
Journal:  Environ Health Perspect       Date:  2010-04-26       Impact factor: 9.031

5.  Targets of Wnt/ß-catenin transcription in penile carcinoma.

Authors:  Manit Arya; Christopher Thrasivoulou; Rui Henrique; Michael Millar; Ruth Hamblin; Reena Davda; Kristina Aare; John R Masters; Calum Thomson; Asif Muneer; Hitendra R H Patel; Aamir Ahmed
Journal:  PLoS One       Date:  2015-04-22       Impact factor: 3.240

6.  Tissue expression of β-catenin and E- and N-cadherins in chronic hepatitis C and hepatocellular carcinoma.

Authors:  Aldona Kasprzak; Karol Rogacki; Agnieszka Adamek; Karolina Sterzyńska; Wiesława Przybyszewska; Agnieszka Seraszek-Jaros; Celina Helak-Łapaj; Przemysław Pyda
Journal:  Arch Med Sci       Date:  2017-01-19       Impact factor: 3.318

Review 7.  Action and function of Wnt/β-catenin signaling in the progression from chronic hepatitis C to hepatocellular carcinoma.

Authors:  Wenhui Wang; Qiuwei Pan; Gwenny M Fuhler; Ron Smits; Maikel P Peppelenbosch
Journal:  J Gastroenterol       Date:  2016-12-29       Impact factor: 7.527

8.  Salinomycin inhibits proliferation and induces apoptosis of human hepatocellular carcinoma cells in vitro and in vivo.

Authors:  Fan Wang; Lei He; Wei-Qi Dai; Ya-Ping Xu; Dong Wu; Chun-Lei Lin; Shu-Mei Wu; Ping Cheng; Yan Zhang; Miao Shen; Chen-Feng Wang; Jie Lu; Ying-Qun Zhou; Xuan-Fu Xu; Ling Xu; Chuan-Yong Guo
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

9.  SNF2H promotes hepatocellular carcinoma proliferation by activating the Wnt/β-catenin signaling pathway.

Authors:  Yanan Wang; Juanxiu Qin; Qian Liu; Xufen Hong; Tianming Li; Yuanjun Zhu; Lei He; Bing Zheng; Min Li
Journal:  Oncol Lett       Date:  2016-06-07       Impact factor: 2.967

10.  In vivo genome-wide binding interactions of mouse and human constitutive androstane receptors reveal novel gene targets.

Authors:  Ben Niu; Denise M Coslo; Alain R Bataille; Istvan Albert; B Franklin Pugh; Curtis J Omiecinski
Journal:  Nucleic Acids Res       Date:  2018-09-19       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.